Evidence map›Paper›PMID 31415677›Full record

Trial reportPloS one2019

Investigation of base excision repair gene variants in late-onset Alzheimer's disease.

Tugce Ertuzun, Asli Semerci, Mehmet Emin Cakir, Aysegul Ekmekcioglu, Mehmet Oguz Gok, Daniela T Soltys, Nadja C de Souza-Pinto, Ugur Sezerman, Meltem Muftuoglu

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Tugce ErtuzunDepartment of Molecular Biology and Genetics.
Asli SemerciDepartment of Medical Biotechnology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Mehmet Emin CakirDepartment of Neurology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Aysegul EkmekciogluDepartment of Medical Biotechnology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Mehmet Oguz GokDepartment of Medical Biotechnology, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Daniela T SoltysDepartmento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.
Nadja C de Souza-PintoDepartmento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.
Ugur SezermanDepartment of Biostatistics and Medical Informatics, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Meltem MuftuogluDepartment of Molecular Biology and Genetics.ORCID 0000-0001-5372-4780
Kent Hastanesi · TRUniversidade de São Paulo · BRIstanbul Medeniyet University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Base excision repair (BER) defects and concomitant oxidative DNA damage accumulation play a role in the etiology and progression of late-onset Alzheimer's disease (LOAD). However, it is not known whether genetic variant(s) of specific BER genes contribute to reduced BER activity in LOAD patients and whether they are associated with risk, development and/or progression of LOAD. Therefore, we performed targeted next generation sequencing for three BER genes, uracil glycosylase (UNG), endonuclease VIII-like DNA glycosylase 1 (NEIL1) and polymerase β (POLβ) including promoter, exonic and intronic regions in peripheral blood samples and postmortem brain tissues (temporal cortex, TC and cerebellum, CE) from LOAD patients, high-pathology control and cognitively normal age-matched controls. In addition, the known LOAD risk factor, APOE was included in this study to test whether any BER gene variants associate with APOE variants, particularly APOE ε4. We show that UNG carry five significant variants (rs1610925, rs2268406, rs80001089, rs1018782 and rs1018783) in blood samples of Turkish LOAD patients compared to age-matched controls and one of them (UNG rs80001089) is also significant in TC from Brazilian LOAD patients (p<0.05). The significant variants present only in CE and TC from LOAD are UNG rs2569987 and POLβ rs1012381950, respectively. There is also significant epistatic relationship (p = 0.0410) between UNG rs80001089 and NEIL1 rs7182283 in TC from LOAD subjects. Our results suggest that significant BER gene variants may be associated with the risk of LOAD in non-APOE ε4 carriers. On the other hand, there are no significant UNG, NEIL1 and POLβ variants that could affect their protein level and function, suggesting that there may be other factors such as post-transcriptional or-translational modifications responsible for the reduced activities and protein levels of these genes in LOAD pathogenesis. Further studies with increased sample size are needed to confirm the relationship between BER variants and LOAD risk.

Indexed as

BrainDNA RepairPolymorphism, GeneticAgedAged, 80 and overAlzheimer DiseaseApolipoproteins EDNA GlycosylasesDNA Polymerase betaFemaleHumansMaleRisk FactorsUracil-DNA GlycosidaseApoE protein, humanApolipoproteins EDNA GlycosylasesDNA Polymerase betaNEIL1 protein, humanPOLB protein, humanUracil-DNA Glycosidase

Identifiers

PMID31415677
PMCPMC6695184
OpenAlexW2968811797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.